AAAAAA

   
Results: 1-12 |
Results: 12
Analysis of metabolites of glucose pathways in human erythrocytes by analytical isotachophoresis
Authors: Renner, S Prohaska, V Gerber, C Niethammer, D Bruchelt, G
Citation: S. Renner et al., Analysis of metabolites of glucose pathways in human erythrocytes by analytical isotachophoresis, J CHROMAT A, 916(1-2), 2001, pp. 247-253
Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes
Authors: Gerber, CE Bruchelt, G Falk, UB Kimpfler, A Hauschild, O Kuci, S Bachi, T Niethammer, D Schubert, R
Citation: Ce. Gerber et al., Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes, BLOOD, 98(10), 2001, pp. 3097-3105
Effect of amifostine on neuroblastoma during high dose chemotherapy: In vivo and in vitro investigations
Authors: Renner, S Krumpelmann, S Bruchelt, G Wiesinger, H Niethammer, D Klingebiel, T
Citation: S. Renner et al., Effect of amifostine on neuroblastoma during high dose chemotherapy: In vivo and in vitro investigations, ANTICANC R, 20(6B), 2000, pp. 4531-4538
Isotachophoretic analysis of the dihydrofolate reductase reaction in the presence of methotrexate and ascorbic acid
Authors: Renner, S Kuci, Z d'Cruze, H Niethammer, D Bruchelt, G
Citation: S. Renner et al., Isotachophoretic analysis of the dihydrofolate reductase reaction in the presence of methotrexate and ascorbic acid, ELECTROPHOR, 21(14), 2000, pp. 2828-2833
6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter
Authors: Seitz, G Bruchelt, G Kuci, Z Roginsky, VA Wolburg, H Stegmann, HB Niethammer, D
Citation: G. Seitz et al., 6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter, MED PED ONC, 35(6), 2000, pp. 612-615
Neuroblastoma cells expressing the noradrenaline transporter are destroyedmore selectively by 6-fluorodopamine than by 6-hydroxydopamine
Authors: Seitz, G Stegmann, HB Jager, HH Schlude, HM Wolburg, H Roginsky, VA Niethammer, D Bruchelt, G
Citation: G. Seitz et al., Neuroblastoma cells expressing the noradrenaline transporter are destroyedmore selectively by 6-fluorodopamine than by 6-hydroxydopamine, J NEUROCHEM, 75(2), 2000, pp. 511-520
Detection by ELISA of low transferrin levels in bronchoalveolar secretionsof preterm infants
Authors: Gerber, CE Bruchelt, G Gotze-Speer, B Speer, CP
Citation: Ce. Gerber et al., Detection by ELISA of low transferrin levels in bronchoalveolar secretionsof preterm infants, J IMMUNOL M, 233(1-2), 2000, pp. 41-45
Isotachophoretic determination of phosphate splitting from amifostine and p-nitrophenyl phosphate in serum and neuroblastoma cells
Authors: Renner, S Klingebiel, T Niethammer, D Bruchelt, G Meissner, T Eisenbeiss, F
Citation: S. Renner et al., Isotachophoretic determination of phosphate splitting from amifostine and p-nitrophenyl phosphate in serum and neuroblastoma cells, J CHROMAT A, 838(1-2), 1999, pp. 251-257
Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acidis based on different mechanisms
Authors: Girgert, R Vogt, Y Becke, D Bruchelt, G Schweizer, P
Citation: R. Girgert et al., Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acidis based on different mechanisms, CANCER LETT, 137(2), 1999, pp. 167-172
SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation
Authors: Marini, P MacLeod, RAF Treuner, C Bruchelt, G Bohm, W Wolburg, H Schweizer, P Girgert, R
Citation: P. Marini et al., SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation, CANC GENET, 112(2), 1999, pp. 161-164
Presence of bleomycin-detectable free iron in the alveolar system of preterm infants
Authors: Gerber, CE Bruchelt, G Stegmann, H Schweinsberg, F Speer, CP
Citation: Ce. Gerber et al., Presence of bleomycin-detectable free iron in the alveolar system of preterm infants, BIOC BIOP R, 257(1), 1999, pp. 218-222
Clinical implementation of neutron capture therapy
Authors: Gabel, D Pendl, G Wambersie, A Fankhauser, H Larsson, B Piscol, K",Lawazceck,"Duhmke, E Auberger, T Lemmen, P Sauerwein, W Broekart, J Bruchelt, G",Alcober,"Abbe, JC Orenstein, D Thellier, M Gibson, GAB Hopewell, J Adams, CBT East, B Loughlin, T Morris, J Kalef-Ezra, J Tavoni, R Rief, H Chiaraviglio, D Spalding, T Moss, RL Huiskamp, R Bartelink, H Voormolen, JHC Silvestre, ME Carlsson, J Salford, L Larsson, B Hiismaki, P Holsti, L Zsolnay, EM Ebulska-Wasilewska, AC Litvchenko, P Murzin, A
Citation: D. Gabel et al., Clinical implementation of neutron capture therapy, BIOM HLTH R, 24, 1998, pp. 282-287
Risultati: 1-12 |